Physicochemical Properties
| Molecular Formula | C6H11NO2 |
| Molecular Weight | 129.16 |
| Exact Mass | 129.078 |
| CAS # | 498-95-3 |
| PubChem CID | 4498 |
| Appearance | White to off-white solid powder |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 265.8±33.0 °C at 760 mmHg |
| Melting Point | 261ºC (dec.) |
| Flash Point | 114.5±25.4 °C |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.479 |
| LogP | -0.04 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Heavy Atom Count | 9 |
| Complexity | 114 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | XJLSEXAGTJCILF-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C6H11NO2/c8-6(9)5-2-1-3-7-4-5/h5,7H,1-4H2,(H,8,9) |
| Chemical Name | piperidine-3-carboxylic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | GABA Receptor[1] |
| ln Vitro | Applying nipecotic acid (1 mM) to outside-out patches of paraventricular neurones induced inward unitary currents[1]. |
| ln Vivo | The blood-brain barrier (BBB) is not easily crossed by nipecotic acid[2]. |
| References |
[1]. Nipecotic acid directly activates GABA(A)-like ion channels. Br J Pharmacol. 2001 Jul;133(5):673-8. [2]. Design, Synthesis and Enhanced BBB Penetration Studies of L-serine-Tethered Nipecotic Acid-Prodrug. Drug Res (Stuttg). 2021 Feb;71(2):94-103. |
| Additional Infomation | Nipecotic acid is a piperidinemonocarboxylic acid that is piperidine in which one of the hydrogens at position 3 is substituted by a carboxylic acid group. It is a piperidinemonocarboxylic acid and a beta-amino acid. |
Solubility Data
| Solubility (In Vitro) |
H2O: 50 mg/mL (387.12 mM) DMSO: < 1 mg/mL |
| Solubility (In Vivo) |
Solubility in Formulation 1: 50 mg/mL (387.12 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 7.7423 mL | 38.7117 mL | 77.4234 mL | |
| 5 mM | 1.5485 mL | 7.7423 mL | 15.4847 mL | |
| 10 mM | 0.7742 mL | 3.8712 mL | 7.7423 mL |